May 8 |
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
|
May 6 |
IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
|
Apr 18 |
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
|
Apr 12 |
IMNN: IND Application Submitted for Phase 1/2 Trial of Seasonal COVID-19 Vaccine…
|
Apr 11 |
IMUNON regains compliance with Nasdaq's listing rule
|
Apr 11 |
IMUNON Reports Compliance with Nasdaq Listing Requirements
|
Apr 10 |
Imunon files to withdraw registration statement
|
Apr 1 |
Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript
|